← All stories
Markets

Can the Capital Access Window finally revive AIM?

1 source ·1 article ·6h ago AIM ImmunoTech

August is usually a sleepy time for capital markets. Investors head off on their summer jaunts, firms take a breath after a frenzy of results in late July and advisors start mapping out back-to-school plans for September. Not so in the worl…

Covered by 1 outlet

All coverage · 1 article